Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Despite recent advances in substance abuse interventions, a large percentage of clients entering residential treatment for substance use will drop out of treatment prematurely, and of the remaining, many will relapse soon after treatment completion. Previous research indicates that an individual's ability to withstand psychological distress is a key factor necessary to maintain drug and alcohol abstinence and to remain in substance use treatment without absconding. In previous work, Dr. Bornovalova developed a specific distress tolerance treatment called Skills for Improving Distress Intolerance (SIDI). This intervention features skills training in behavioral and acceptance strategies and intentional clinical exposure to emotional distress. SIDI was developed and piloted with a sample of urban drug users seeking treatment in a residential facility. Individuals receiving SIDI exhibited greater improvement in distress tolerance than those in two comparison groups (receiving treatment-as-usual and supportive counseling).
Current study. The investigators received NIDA funding to conduct a randomized clinical trial with 325 clients entering a residential substance use treatment facility. Study participants will be randomized into two treatment groups: (1) those receiving SIDI and (2) those receiving Supportive Counseling (SC). Participants will receive 10 treatment sessions over a period of 4 months. Then, the investigators will follow clients for one year to examine treatment retention and abstinence.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SIDI | Experimental | Skills for Improving Distress Intolerance treatment protocol: individual, manualized treatment aimed at improving distress intolerance |
|
| SC | Placebo Comparator | supportive counseling; psychological placebo/talk therapy - aimed at controlling for non-specific therapeutic factors |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SIDI | Behavioral |
|
| |
| SC |
| Measure | Description | Time Frame |
|---|---|---|
| abstinence at 1, 3, 6 & 12 month follow-up | Measured via biological verification and timeline follow-back | 1, 3, 6 month follow-up post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| distress tolerance | ability to tolerate psychological distress | 1, 3, 6 month follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| successful/unsuccessful completion of residential addictions treatment | successful/unsuccessful completion of residential addictions treatment | Baseline, post-treatment (at 3 month mark in residential facility), successful discharge within 6 months from residential facility |
| time in jail |
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kelly Lane, BA | Contact | 813-974-9030 | kellylane@mail.usf.edu | |
| Marina Bornovalova, PhD | Contact | 3123990983 | bornovalova@usf.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Agency for Community Treatment Services, Inc | Recruiting | Tarpon Springs | Florida | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39541537 | Derived | Fatimah H, Hunter MD, Bornovalova MA. Modeling the dynamics of addiction relapse via the double-well potential system. J Psychopathol Clin Sci. 2025 Jan;134(1):69-80. doi: 10.1037/abn0000960. Epub 2024 Nov 14. | |
| 34521057 | Derived | Choate AM, Gorey C, Rappaport LM, Wiernik BM, Bornovalova MA. Alternative model of personality disorders traits predict residential addictions treatment completion. Drug Alcohol Depend. 2021 Nov 1;228:109011. doi: 10.1016/j.drugalcdep.2021.109011. Epub 2021 Sep 1. |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Mar 4, 2024 | |
| Reset | Apr 2, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Mar 4, 2024 | Apr 2, 2024 |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
|
|
measured by public records (# of days in jail by each timepoint) |
| 1, 3, 6 month follow-up in community |
| psychiatric distress | psychiatric distress on brief symptom inventory | post-treatment at 3 month mark in residential facility, 1, 3, 6 month follow-up in community |
| maladaptive personality | change in maladaptive personality on the Personality Inventory for DSM5 | post-treatment (at 3 month mark in residential facility), 1, 3, 6 month follow-up in community |